Canopy Growth (CGC) Stock Outlook December 2025: Debt Prepayment, Lawsuit Pressure and a High‑Risk Turnaround
Canopy Growth Corp remains one of the most volatile names in global cannabis — and 2025 has been no exception.
Tilray Stock Today, November 23, 2025: TLRY Under $1 as AI Trading Signals, Hemp Rules and Big Holders Collide
Tilray Brands stock is back in the spotlight this Sunday, November 23, 2025, for all the reasons that make cannabis names both fascinating and stressful to follow:the share price has slipped back under $1, new AI-driven trading plans dropped this morning, a fresh “millionaire maker” think-piece is circulating, and regulators are pulling the sector in opposite directions.
Tilray Brands (TLRY) on November 23, 2025: Stock Under $1, Fresh AI Trading Signals, and a Tug-of-War Between Fundamentals and Regulation
Tilray Brands, Inc. is back in focus today as new AI-driven trading signals, updated valuation models, and recent analyst forecasts collide with a volatile share price that’s again trading under $1.
Akanda Corp. (AKAN) Today: Full Cultivation License Push, Telecom Growth and Stock Reaction – November 14, 2025
Akanda Corp. is back in the news today after outlining the next steps toward a full Health Canada cultivation license at its British Columbia cannabis site, while commentators highlight the company’s unusual mix of Mexican telecom infrastructure and Canadian cannabis “optionality.” Newsfile+1
Canopy Growth (CGC) Lifts ‘Going Concern’ Doubts as Cash Tops Debt; Q2 FY2026 Shows 30% Canada Adult‑Use Growth
Canopy Growth Corporation reported second‑quarter fiscal 2026 results today that highlight improving operations, tighter cost control, and a stronger balance sheet. The company ended the quarter with C$298 million in cash and cash equivalents, exceeding total debt by C$70 million—and said the conditions that had previously raised “substantial doubt” about its ability to continue as a going concern have been resolved. Canopy Growth
SNDL Inc. Stock Plunges After Q3 2025 Earnings – What’s Next for This Cannabis Retail Giant?
SNDL Inc., one of Canada’s largest cannabis and liquor retailers, just released its third-quarter 2025 results, sending its stock price tumbling. Below is a summary of key facts, followed by an in-depth analysis of the latest news, financials, expert opinions, forecasts, and how SNDL compares to peers in the cannabis sector.
From Cannabis Clinics to Bitcoin Billions: KindlyMD (NAKA) Stock’s Wild 2025 Ride
Market Analysis & Forecast: For now, analysts and investors appear in “wait and see” mode. Near-term catalysts will be pivotal. These include the finalization of the Antalpha $250M convertible deal – which would inject capital but on what terms? – and the company’s next earnings report. If Bitcoin’s price continues to climb in late 2025, it could boost KindlyMD’s asset value and perhaps its stock; conversely, a crypto downturn or interest rate spike could hurt both the value of its BTC and its ability to raise funds cheaply. Price forecasts vary widely: some Wall Street firms see NAKA recovering to a few dollars, while rating agencies like Weiss effectively warn it could go lower. Given the speculative nature of this stock, extreme swings are likely to persist.
Urban-gro Stock Skyrockets on Flashy Merger Deal – Is This the Cannabis Builder’s Comeback?
Urban-gro’s announcement of a planned merger with Flash Sports & Media sent its battered stock soaring on October 14. The company revealed it signed a binding LOI to combine with Flash, a private sports-media firm, in what is effectively a reverse mergertipranks.com. Under the proposal, Flash will be absorbed into new Urban-gro subsidiaries, and Flash’s shareholders will receive new Urban-gro shares equal to 19.99% of UGRO’s pre-merger common stock, plus a new series of preferred shares that convert to common upon shareholder approvalsec.govsec.gov. Once the dust settles, Flash’s owners would end up with roughly 90% of the post-merger companysec.gov.
Tilray’s 300% Rally and Surprise Profit: Is the Cannabis Comeback Real?
Tilray Brands kicked off its fiscal 2026 with better-than-expected results, signaling that aggressive cost-cutting and diversification efforts are bearing fruit. The company’s Q1 FY2026 revenue hit $209.5 million, a 5% increase over last year’s quarter stocktitan.net. More impressively, Tilray managed to swing to a net profit of $1.5 million – a stark improvement from the -$34.7 million loss in the prior-year period stocktitan.net stocktitan.net. This marks one of Tilray’s first profitable quarters since its 2018 IPO, a milestone achieved through tighter operational discipline. Adjusted EBITDA came in at $10.2 million, indicating improving core profitability stocktitan.net.
Tilray Stock Skyrockets 300% on Cannabis Reform Hopes – Is TLRY’s Rally Sustainable?
Tilray’s stock has been on a tear in recent months, staging a stunning turnaround from penny-stock levels. The share price has quadrupled since early July – rising from well under $0.5 to around $1.7 by early October Nasdaq. Year-to-date, TLRY is up ~22% after being down over 20% mid-year Talkmarkets Hi Plainscoop. This rebound has rescued Tilray from the brink of a Nasdaq delisting – the company had even sought a compliance extension when its shares languished below $1 in the summer Hi Plainscoop.
Tilray Stock Skyrockets 300% on Cannabis Reform Hopes – Will TLRY’s Rally Last?
Tilray’s stock has been on a wild ride in early October 2025, propelled by a flurry of cannabis policy news. In the first week of October, TLRY jumped over 8% in one day after an apparent breakthrough in U.S. marijuana reform sentimentnasdaq.comnasdaq.com. The trigger: several prominent Republican senators voiced unexpected support for easing federal cannabis laws, and former President Donald Trump – now in his second term – signaled openness to rescheduling marijuana. MarijuanaMoment reports that in late September, Trump shared a video touting CBD’s health benefits for seniors, and GOP Senators Lisa Murkowski said moving cannabis to Schedule III “is totally a game changer” while Kevin Cramer confirmed Trump “has said it… if he reschedules, that is a big deal”marijuanamoment.netmarijuanamoment.net. Such rhetoric from traditionally resistant lawmakers shocked the market and “seemed to take a little step forward” the slow march toward U.S. marijuana legalizationnasdaq.com. Cannabis stocks across the board rallied on the news, with Tilray notable as one of the biggest gainers, climbing over 8% that daynasdaq.com.